Startling admission by defence at bush bash shooting trialAlgert Global LLC acquired a new position in Ubiquiti Inc. ( NYSE:UI – Free Report ) in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 3,779 shares of the company’s stock, valued at approximately $838,000. A number of other hedge funds have also bought and sold shares of the business. Pacer Advisors Inc. bought a new position in shares of Ubiquiti in the third quarter worth $7,030,000. Millennium Management LLC grew its holdings in Ubiquiti by 86.2% during the 2nd quarter. Millennium Management LLC now owns 58,349 shares of the company’s stock valued at $8,499,000 after buying an additional 27,011 shares in the last quarter. SW Investment Management LLC increased its position in shares of Ubiquiti by 9.1% during the second quarter. SW Investment Management LLC now owns 300,000 shares of the company’s stock valued at $43,698,000 after buying an additional 25,000 shares during the period. Vanguard Group Inc. lifted its holdings in shares of Ubiquiti by 24.1% in the first quarter. Vanguard Group Inc. now owns 97,817 shares of the company’s stock worth $11,332,000 after buying an additional 18,986 shares in the last quarter. Finally, AQR Capital Management LLC boosted its position in shares of Ubiquiti by 88.8% in the second quarter. AQR Capital Management LLC now owns 23,546 shares of the company’s stock valued at $3,372,000 after acquiring an additional 11,076 shares during the period. 4.00% of the stock is currently owned by hedge funds and other institutional investors. Ubiquiti Price Performance Shares of NYSE:UI opened at $346.49 on Friday. The company’s fifty day moving average price is $275.08 and its 200-day moving average price is $204.09. The firm has a market capitalization of $20.95 billion, a price-to-earnings ratio of 53.64 and a beta of 1.13. Ubiquiti Inc. has a one year low of $104.24 and a one year high of $366.00. The company has a debt-to-equity ratio of 2.80, a current ratio of 2.54 and a quick ratio of 1.32. Ubiquiti Announces Dividend Wall Street Analyst Weigh In UI has been the topic of a number of analyst reports. Barclays upped their target price on shares of Ubiquiti from $104.00 to $236.00 and gave the stock an “underweight” rating in a report on Monday, November 11th. StockNews.com upgraded Ubiquiti from a “hold” rating to a “buy” rating in a research report on Sunday, November 17th. Finally, BWS Financial upped their target price on Ubiquiti from $240.00 to $385.00 and gave the stock a “buy” rating in a research note on Monday, November 11th. Check Out Our Latest Stock Report on UI Ubiquiti Company Profile ( Free Report ) Ubiquiti Inc develops networking technology for service providers, enterprises, and consumers. The company develops technology platforms for high-capacity distributed Internet access, unified information technology, and consumer electronics for professional, home, and personal use. Its service provider product platforms offer carrier-class network infrastructure for fixed wireless broadband, wireless backhaul systems, and routing and related software; and enterprise product platforms provide wireless LAN infrastructure, video surveillance products, switching and routing solutions, security gateways, door access systems, and other WLAN products. Further Reading Receive News & Ratings for Ubiquiti Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ubiquiti and related companies with MarketBeat.com's FREE daily email newsletter .
Cowboys star G Zack Martin doubtful to play vs. CommandersNEW YORK — Stoli Group USA, the owner of the namesake vodka , has filed for bankruptcy as it struggled to contend with slowing demand for spirits, a major cyberattack that has snarled its operations and several years of fighting Russia in court. The company in its bankruptcy filing said it is “experiencing financial difficulties” and lists between $50 million and $100 million in liabilities. Stoli vodka and Kentucky Owl bourbon will continue to be available on store shelves while the company navigates the Chapter 11 process, which only pertains to its U.S. business. Until 2022, Stoli was sold as Stolichnaya in the United States, which loosely translates to “capital city” in Russian. The company shortened its title following Russia’s invasion of Ukraine and boycotts against Russian-branded vodkas . Stoli Group’s founder, Russian-born billionaire Yuri Shefler, was exiled from that nation in 2000 because of his opposition to President Vladimir Putin. People are also reading... ‘I don’t care who’s played': Nebraska’s Dana Holgorsen on personnel changes at tight end Search warrants lead to arrest of man in narcotics investigation Blue Springs family to host 2025 Cattleman's Ball They fell in love with Beatrice. So they opened a store in downtown. At the courthouse, Nov. 30, 2024 La Segoviana finds new home in Court Street Plaza Hospice foundation helps with extra support At the courthouse, Nov. 23, 2024 Fall Farmers Market and Brunch planned for Saturday Board of Supervisors denies permit for Filley telecom tower 'The Message' religious sect sprouts destructive groups across globe Dale G. Lunsford Shatel: Emotions are still simmering, but Nebraska delivered the bottom line for 2024 — a bowl game Spreading kindness one butterfly at a time Black Friday starts a busy weekend of serving customers Intel announced on December 2 that CEO Pat Gelsinger has resigned after a difficult stint at the company. The once-dominant chipmaker’s stock cratered as it missed the AI boom and was surpassed by most of its rivals. The liquor has long been marketed as a Russian vodka, but its production facilities have been in Latvia for several decades. Stoli Group is a unit of Luxembourg-based SPI Group, which owns other spirit and wine brands. “The Stoli Group has been targeted by the Russian Federation since it was formed nearly 25 years ago,” said Stoli Group CEO Chris Caldwell in a statement. “Earlier this year the company and our owner were both named by the Russian state as ‘extremist groups working against Russia’s interests.’” Its ongoing legal battle with the Russia government has forced Stoli to “spend dozens of millions of dollars on this long-term court battle across the globe with the Russian authorities,” according to its court filing. Caldwell also said that Stoli’s global operations has been a “victim of a malicious cyber attack” that has forced the company to operate “entirely manually while the systems are rebuilt.” A slowdown in demand for alcohol has crushed several company’s bottom lines following the pandemic when people were stuck at home and stocked up. Stoli’s filings said that it has seen a “decline and softening of demand for alcohol and spirits products post-Covid and especially beginning in 2023 and continuing into 2024.” Stoli Group USA, maker of Stoli vodka, has filed for bankruptcy due to slowing demand for spirits, a major cyberattack, and ongoing legal battles with Russia. The-CNN-WireTM & © 2024 Cable News Network, Inc., a Warner Bros. Discovery Company. All rights reserved. Get the latest local business news delivered FREE to your inbox weekly.
IRVINE, Calif., Dec. 02, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. NARI ("Inari"), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other vascular diseases, announced today that on December 1, 2024, it received national reimbursement approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) for its ClotTriever Thrombectomy System for DVT. This announcement follows the regulatory approval of the ClotTriever system by the Pharmaceuticals and Medical Devices Agency (PMDA) in December 2023. Due to ClotTriever's unique mechanism of action for complete, wall-to-wall thrombus removal in patients suffering from DVT, MHLW created a new functional category that is separate from other catheter-based therapies. This new functional category comes with a reimbursement premium based upon ClotTriever's wealth of clinical data showing safety and efficacy in removing various types of thrombi. To facilitate commercialization of the ClotTriever system in Japan, Inari has entered into a distribution agreement with Medikit Co., Ltd., a market leading vascular medical device manufacturer serving Japan, the U.S. and over 30 other countries. With this new partnership, Inari plans to accelerate initiation of its 100-patient Post Market Surveillance study, followed by broader commercial expansion. "MHLW's approval of reimbursement for ClotTriever under a newly designated functional category marks a transformative milestone for Inari in Japan," said Drew Hykes, Chief Executive Officer of Inari. "This decision underscores the value of ClotTriever in addressing unmet clinical needs, and we are thrilled to collaborate with Medikit to bring this innovative solution to Japanese DVT patients, improving lives and advancing care in the near future. Over time, we look forward to bringing our broader portfolio of purpose-built tools to the Japanese market." The ClotTriever system is 510(k)-cleared by U.S. FDA and CE-Marked for treatment of DVT. More than 75,000 procedures have been conducted with ClotTriever globally. Recently, two-year outcomes were reported from the 500-patient ClotTriever CLOUT Registry showing a strong safety profile, significant clot removal, and low rates of post-thrombotic syndrome. 1 , 2 , 3 ClotTriever is the most studied thrombectomy device for DVT, including the ongoing Randomized Controlled Trial, DEFIANCE, comparing ClotTriever to anticoagulation alone for patients with DVT. 4 About Inari Medical, Inc. Patients first. No small plans. Take care of each other. These are the guiding principles that form the ethos of Inari Medical. We are committed to improving lives in extraordinary ways by creating innovative solutions for both unmet and underserved health needs. In addition to our purpose-built solutions, we leverage our capabilities in education, clinical research, and program development to improve patient outcomes. We are passionate about our mission to establish our treatments as the standard of care for venous thromboembolism and four other targeted disease states. We are just getting started. Learn more at www.inarimedical.com and connect with us on LinkedIn , X (Twitter) , and Instagram . About Medikit Co., Ltd. Medikit Co., Ltd., based in Tokyo, established in 1973, is a global medical device company and is publicly traded on the Tokyo Stock Exchange (Code: 7749). Medikit's mission is to deliver the highest standards of excellence in operating as a health care company whose products and services help to enhance healthy life by minimizing unnecessary suffering and death from disease. Medikit is a market leader in Japan in interventional products, including vascular access devices such as hemodialysis catheters, intravenous catheters, sheaths, and guiding catheters. Medikit products are sold in Japan, the United States, and over 30 other countries. The company has sales, R&D, and manufacturing capabilities with more than 1,300 consolidated employees. For more information, visit the company's website at www.medikit.co.jp . Investor Contact: Neil Bhalodkar IR@inarimedical.com ___________________________ 1 Bisharat, et al. One-Year Clinical Outcomes Following Mechanical Thrombectomy for Deep Vein Thrombosis: A CLOUT Registry Analysis. JSCAI. 2024. 2 Shaikh, et al. Six-Month Outcomes of Mechanical Thrombectomy for Treating Deep Vein Thrombosis: Analysis from the 500-Patient CLOUT Registry. Cardiovasc Int Rad. 2023. 3 Dexter, D. Interim two-year outcomes from the fully enrolled CLOUT registry. Presented at AVF 2024 (Tampa, FL). 4 Abramowitz, et al. Rationale and Design of the DEFIANCE Study: A Randomized Controlled Trial of Mechanical Thrombectomy Versus Anticoagulation Alone for Iliofemoral Deep Vein Thrombosis. American Heart Journal. doi.org/10.1016/j.ahj.2024.10.016 © 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
NoneLast holiday for Biden White House celebrates 'a season of peace and light'NEW YORK (AP) — Technology stocks pulled Wall Street to another record amid a mixed Monday of trading. The S&P 500 rose 0.2% from its all-time high set on Friday to post a record for the 54th time this year. The Dow Jones Industrial Average fell 128 points, or 0.3%, while the Nasdaq composite gained 1%. Javascript is required for you to be able to read premium content. Please enable it in your browser settings.
Enbridge: Dividend Champion Deeply Undervalued
FOREST HILL, Md. , Dec. 2, 2024 /PRNewswire/ -- Cadmium, the leading provider of event and learning management solutions, announced today that Sean Brady will take over as Chief Executive Officer effective December 2 . Sean succeeds current CEO John Pierson, who will transition into retirement while remaining an active Board member. " Sean Brady brings a wealth of experience and a fresh perspective that will propel Cadmium to new heights," said John Pierson . "I'm committed to working closely with Sean as an advisor to ensure a seamless transition. I'm confident his leadership will enable Cadmium to continue to thrive, and I wish him all the best in this exciting role." Sean Brady joins Cadmium with a proven track record of driving growth and innovation. Most recently, he served as President and COO at Maropost, where he oversaw strategic operations and enhanced company performance. His career includes leadership roles such as CEO of Terminus, where he championed customer engagement strategies, and President of Emarsys Americas, where he played a pivotal role in its acquisition by SAP. Earlier in his career, Sean helped transform ExactTarget into a multibillion-dollar enterprise, culminating in its acquisition by Salesforce. "I am honored to join Cadmium as CEO and lead its next chapter of innovation and growth," said Sean Brady . "Cadmium's dedication to empowering associations with transformative technology aligns with my vision for fostering impactful solutions that create lasting value for customers." Rushi Kulkarni , Managing Director at Symphony Technology Group (STG) and Cadmium Board member, added: "We are deeply grateful for John Pierson's leadership, which established Cadmium as a trailblazer in event and continuing education technology. As we wish John a joyful retirement, we are confident Sean's expertise and vision will drive Cadmium's continued success." About Cadmium Cadmium delivers integrated solutions that empower associations to manage events and continuing education seamlessly. Focused on creating transformative learning experiences, Cadmium fosters community and drives meaningful change. Learn more at gocadmium.com. Contact: Jessie Reyes Director of Marketing, Cadmium [email protected] SOURCE Cadmium'Cash cow': Alberta to reduce photo radar sites by 70 per centStock market today: Wall Street drifts lower as it waits for inflation dataCharles Schwab Investment Management Inc. raised its stake in shares of S&T Bancorp, Inc. ( NASDAQ:STBA – Free Report ) by 3.1% in the 3rd quarter, according to its most recent disclosure with the SEC. The firm owned 1,432,510 shares of the financial services provider’s stock after purchasing an additional 43,268 shares during the period. Charles Schwab Investment Management Inc.’s holdings in S&T Bancorp were worth $60,122,000 as of its most recent SEC filing. A number of other hedge funds and other institutional investors have also bought and sold shares of the stock. Louisiana State Employees Retirement System lifted its position in shares of S&T Bancorp by 1.6% during the 2nd quarter. Louisiana State Employees Retirement System now owns 19,200 shares of the financial services provider’s stock valued at $641,000 after buying an additional 300 shares in the last quarter. Hennion & Walsh Asset Management Inc. boosted its position in shares of S&T Bancorp by 2.8% in the third quarter. Hennion & Walsh Asset Management Inc. now owns 12,103 shares of the financial services provider’s stock worth $508,000 after purchasing an additional 326 shares during the period. The Manufacturers Life Insurance Company boosted its position in shares of S&T Bancorp by 2.6% in the second quarter. The Manufacturers Life Insurance Company now owns 19,436 shares of the financial services provider’s stock worth $649,000 after purchasing an additional 498 shares during the period. GAMMA Investing LLC increased its stake in shares of S&T Bancorp by 80.8% in the third quarter. GAMMA Investing LLC now owns 1,177 shares of the financial services provider’s stock worth $49,000 after purchasing an additional 526 shares in the last quarter. Finally, HBK Sorce Advisory LLC raised its position in shares of S&T Bancorp by 4.2% during the 2nd quarter. HBK Sorce Advisory LLC now owns 14,557 shares of the financial services provider’s stock valued at $486,000 after purchasing an additional 584 shares during the period. Hedge funds and other institutional investors own 65.22% of the company’s stock. Analysts Set New Price Targets Separately, StockNews.com raised shares of S&T Bancorp from a “sell” rating to a “hold” rating in a report on Thursday, October 24th. Insider Activity In related news, Director Frank J. Palermo, Jr. sold 4,982 shares of the stock in a transaction that occurred on Wednesday, November 13th. The stock was sold at an average price of $43.21, for a total transaction of $215,272.22. Following the completion of the transaction, the director now directly owns 23,143 shares of the company’s stock, valued at approximately $1,000,009.03. This represents a 17.71 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link . Company insiders own 1.38% of the company’s stock. S&T Bancorp Stock Down 1.3 % Shares of STBA opened at $42.79 on Friday. The business’s 50 day moving average is $40.89 and its 200 day moving average is $38.49. The company has a current ratio of 0.99, a quick ratio of 0.99 and a debt-to-equity ratio of 0.08. S&T Bancorp, Inc. has a 12-month low of $27.43 and a 12-month high of $45.79. The company has a market capitalization of $1.64 billion, a PE ratio of 12.19 and a beta of 0.80. S&T Bancorp ( NASDAQ:STBA – Get Free Report ) last released its quarterly earnings data on Thursday, October 17th. The financial services provider reported $0.85 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.82 by $0.03. S&T Bancorp had a net margin of 23.69% and a return on equity of 10.25%. The firm had revenue of $96.35 million for the quarter, compared to analysts’ expectations of $98.90 million. Research analysts expect that S&T Bancorp, Inc. will post 3.36 earnings per share for the current fiscal year. S&T Bancorp Increases Dividend The business also recently disclosed a quarterly dividend, which was paid on Thursday, November 21st. Shareholders of record on Thursday, November 7th were issued a dividend of $0.34 per share. This represents a $1.36 annualized dividend and a dividend yield of 3.18%. The ex-dividend date of this dividend was Thursday, November 7th. This is an increase from S&T Bancorp’s previous quarterly dividend of $0.33. S&T Bancorp’s dividend payout ratio is 38.75%. S&T Bancorp Profile ( Free Report ) S&T Bancorp, Inc operates as the bank holding company for S&T Bank that engages in the provision of retail and commercial banking products and services. The company operates through six segments: Commercial Real Estate, Commercial and Industrial, Commercial Construction, Business Banking, Consumer Real Estate, and Other Consumer. Further Reading Want to see what other hedge funds are holding STBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for S&T Bancorp, Inc. ( NASDAQ:STBA – Free Report ). Receive News & Ratings for S&T Bancorp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for S&T Bancorp and related companies with MarketBeat.com's FREE daily email newsletter .
Sierra Capital LLC Sells 700 Shares of NVIDIA Co. (NASDAQ:NVDA)Charleston Southern grabs late lead, stuns host Miami
Beware! Now AI Can Detect Your Moves on RoadAston Villa’s impressive Champions League debut continued as they strengthened their chances of automatic qualification to the last 16 after a 3-2 win at RB Leipzig. Ross Barkley’s 85th-minute winner gave them victory after they had twice squandered the lead in Germany. John McGinn and Jhon Duran goals at the start of each half were cancelled out by Lois Openda and Christoph Baumgartner. But Barkley had the final say less than two minutes after coming off the bench as his deflected effort earned the points which sent his side third in the new Champions League league phase. The top eight automatically qualify for the next stage and with games against Monaco and Celtic to come, Unai Emery’s men are a good bet to avoid the need for a play-off round in their first foray in this competition. Leipzig are out, having lost all six of their games. Villa enjoyed a dream start and were ahead with less than three minutes on the clock. Matty Cash, playing in a more advanced position on the right, crossed for Ollie Watkins, who nodded down into the path of McGinn and the skipper made no mistake from close range. That gave the visitors confidence and they had enough chances in the first 15 minutes to have the game wrapped up. Lucas Digne’s cross from the left was begging to be converted but Watkins could not make contact from close range and then Morgan Rogers shot straight at Leipzig goalkeeper Peter Gulacsi. Then Youri Tielemans found himself with time and space on the edge of the area from Watkins’ tee-up but the Belgium international disappointingly dragged wide. All that good work was undone in the 27th minute, though, as Emiliano Martinez was left red-faced. The Argentinian was too casual waiting to collect Nicolas Seiwald’s long ball and Openda nipped in to get the ball first and tap into an empty net. pic.twitter.com/LGoAMrLkQy — Aston Villa (@AVFCOfficial) December 10, 2024 Duran was introduced at the break and needed just a couple of minutes to fire a warning when he drilled wide after a loose ball fell to him 14 yards out. But the Colombian got his goal in the 52nd minute, though it was another moment for the goalkeeper to forget. Duran was invited to drive forward and unleashed a 25-yard shot, which was hardly an Exocet, but still was too much for Gulacsi, who barely even jumped. It was his 10th goal of the season and sixth from the bench as he continues his super-sub role. 😍 pic.twitter.com/ZHeVFiYUW9 — Aston Villa (@AVFCOfficial) December 10, 2024 The striker was not complaining and he thought he had doubled his tally shortly after when he converted Cash’s centre but the provider was ruled offside by VAR. Five minutes later, Villa found themselves pegged back again with a finish of real quality. Openda was sent clear by another long ball and his cross was perfect for Baumgartner to cushion a far-post volley back across goal and into the corner. Digne brought a save out of Gulacsi and then Openda shot straight at Martinez as both sides pushed for a winner. It was Villa who got it as Barkley saw his deflected effort wrong-foot Gulacsi and hit the back of the net.
AP News Summary at 4:50 p.m. ESTHow a fantasy oil train may help the Supreme Court gut a major environmental law
The Biometric Technology Market Share Reach USD 127.32 Billion by 2030, Registering 14.1% of CAGRRecovering from groin surgery, the midfielder has missed Palace’s past four league matches but is back running and expected to rejoin group training after Tuesday’s clash with Ipswich. England international Wharton is targeting a return during the week Palace face Brighton and Arsenal twice. The aim is to have Wharton ready to face the Seagulls on December 15th, but Glasner acknowledged that would be the case in a perfect world. “If everything goes perfectly, then Brighton away,” Glasner said . “He will have his first training session with us after the Ipswich game - he didn’t train until now. “In the next three-game week [Brighton-Arsenal-Arsenal], he will be available if there are no setbacks during his integration into the team."